SiRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration

Journal of Molecular Signaling

Volumn 7, Issue , 2012, Pages

  McHugh, Douglas ^a   Wager Miller, James ^a   Page, Jeremy ^a   Bradshaw, Heather B ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Abnormal cannabidiol receptor; Cellular migration; Endocannabinoid; GPR18; Microglia; NAGly

Indexed keywords

EID: 84864139411     PISSN: None     EISSN: 17502187     Source Type: Journal    
DOI: 10.1186/1750-2187-7-10     Document Type: Article

References (22)

1. Schlicker E, Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 2001, 22:565-572. 10.1016/S0165-6147(00)01805-8, 11698100.
2. Pertwee RG, Ross RA. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 2002, 66:101-121. 10.1054/plef.2001.0341, 12052030.
3. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 2003, 23:1398-1405.
4. Franklin A, Stella N. Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. Eur J Pharmacol 2003, 474:195-198. 10.1016/S0014-2999(03)02074-0, 12921861.
5. Begg M, Pacher P, Bátkai S, Osei-Hyiaman D, Offertáler L, Mo FM, Liu J, Kunos G. Evidence for novel cannabinoid receptors. Pharmacol Ther 2005, 106:133-145. 10.1016/j.pharmthera.2004.11.005, 15866316.
6. Mackie K, Stella N. Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J 2006, 8:E298-E306. 3231556, 16796380.
7. Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 1999, 96:14136-14141. 10.1073/pnas.96.24.14136, 24203, 10570211.
8. Offertáler L, Mo F-M, Batkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol 2003, 63:699-705. 10.1124/mol.63.3.699, 12606780.
9. Mo FM. Offertáler, Kunos G: Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Eur J Pharmacol 2004, 489:21-27. 10.1016/j.ejphar.2004.02.034, 15063151.
10. Vaccani A, Massi P, Colombo A, Rubino T, Palolaro D. Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. BJP 2005, 144:1032-1036.
11. McHugh D, Hu SS-J, Rimmerman N, Juknat A, Vogel Z, Walker JM, Bradshaw HB. N-Arachidonoyl glycine potently drives directed BV-2 microglial migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci 2010, 11:44. 10.1186/1471-2202-11-44, 2865488, 20346144.
12. McHugh D, Page J, Dunn E, Bradshaw HB. Δ9-Tetrahydrocannabinol and N-arachidonoyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. BJP 2012, 165:2414-2424.
13. Bradshaw H, Rimmerman N, Hu S, Benton V, Stuart J, Masuda K, Cravatt B, O'Dell D, Walker JM. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways. BMC Biochem 2009, 10:14. 10.1186/1471-2091-10-14, 2689249, 19460156.
14. Burstein SH, Rossetti RG, Yagen B, Zurier RB. Oxidative metabolism of anandamide. Prostaglandins Other Lipid Mediat 2000, 61:29-41. 10.1016/S0090-6980(00)00053-8, 10785540.
15. Huang SM, Bisogno T, Petros TJ, Chang SY, Zavitsanos PA, Zipkin RE, Sivakumar R, Coop A, Maeda DY, De Petrocellis L, et al. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem 2001, 276:42639-42644. 10.1074/jbc.M107351200, 11518719.
16. Sheskin T, Hanus L, Slager J, Vogel Z, Mechoulam R. Structural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor. J Med Chem 1997, 40:659-667. 10.1021/jm960752x, 9057852.
17. Kohno M, Hasegawa H, Inoue A, Muraoka M, Miyazaki T, Oka K, Yasukawa M. Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophyl Res Comm 2006, 347:827-832.
18. Oh DY, Yoon JM, Moon MJ, Hwang J-I, Choe H, Lee JY, Kim JI, Kim S, Rhim H, O'Dell DK, et al. Identification of Farnesyl Pyrophosphate and N-Arachidonylglycine as Endogenous Ligands for GPR92. J Biol Chem 2008, 283:21054-21064. 10.1074/jbc.M708908200, 2475705, 18499677.
19. Wagner JA, Varga K, Jarai Z, Kunos G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 1999, 33:429-434. 10.1161/01.HYP.33.1.429, 9931142.
20. Carp H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med 1982, 155:264-275. 10.1084/jem.155.1.264, 2186576, 6274994.
21. Chadwick VS, Mellor DM, Myers DB, Selden AC, Keshavarzian A, Broom MF, Hobson CH. Production of peptides inducing Chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand J Gastroenterol 1988, 23:121-128.
22. McHugh D, Tanner C, Mechoulam R, Pertwee RG, Ross RA. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. Mol Pharmacol 2008, 73:441-450.